Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Boostrix Booster in Young Adults
NCT01738477Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2013
- Primary completion
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) in Tetanus, diphtheria, pertussis, sponsored by GSK. Started Jan 2013; status: completed.
02
Drugs
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT01738477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01738477.